Search results for: 'Preferred Destination for Early Phase Clinical Trials'

Cancer treatment technologies are playing an instrumental role in the effective removal of cancerous tumors through radiation and non-radiation therapies. These therapies offer highly localized, minimally invasive/non-invasive, and personalized treatment options that support effective tumor removal.The growing burden of cancer cases globally—primar...

The commercial vehicle industry is at the cusp of a major transformation that will change the dynamics of the supply chain and logistics industry. Frost & Sullivan has examined the top 10 CV trends that will have the highest impact on the commercial vehicle market in the upcoming years. The CASE (connected, autonomous, safe, and electric) strate...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

The ICU is the most data-intensive part of the hospital, as continuous monitoring of patient health generates a huge volume of crucial data valuable for clinical decision making and future research. With digitalization, it is now easy and efficient to use analytics and connectivity solutions to analyze this data and draw insights for better care de...

Clinical documentation using the electronic medical record (EMR) is the base for performing coding. Coding is predominantly done through manual work performed by a combination of coding/data management teams enabled by EMR, with few hospitals investing in specialized computer assisted coding (CAC) solutions. Majority of the hospitals are aware of t...

Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...

The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interventional and image-guided therapy; physiology and f...

Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...

In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...